Skip to content

Topic

biotechnology

8 markets across Kalshi and Polymarket, $534 traded today.

MarketChance24hBest priceVolume 24h
FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)EconomicsEnds Dec 31, 202684%—Kalshi87¢$495
FDA decision: Ivonescimab by Summit Therapeutics (in 2026)EconomicsEnds Dec 31, 202685%—Kalshi88¢$28
When will the FDA approve Intellia Therapeutics' lonvo-z?Before July 2027Tech & ScienceEnds Jun 30, 202788%—Kalshi92¢$10
When will Beam Therapeutics submit a BLA for Risto-cel?before 2027Tech & ScienceEnds Sep 1, 202659%—Kalshi62¢$2
Will the FDA approve VERVE-102?Before 2035Tech & ScienceEnds Dec 31, 202984%—Kalshi87¢—
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)EconomicsEnds Dec 31, 202689%—Kalshi92¢—
FDA decision: BBP-418 by Ml Bio Solutions Inc. (in 2026)EconomicsEnds Dec 31, 202691%—Kalshi93¢—
Eli Lilly licenses Peptron’s SmartDepot by October 7?EconomicsEnds Oct 6, 202613%—Polymarket13¢—